Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02000440
Brief Title: A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS)

First Submitted : November 27, 2013
First Submitted that Met QC Criteria : November 27, 2013
First Posted : December 4, 2013 (Estimate)

Results First Submitted : March 1, 2017
Results First Submitted that Met QC Criteria : May 11, 2017
Results First Posted : June 12, 2017

Certification/Extension First Submitted : June 24, 2016
Certification/Extension First Submitted that Met QC Criteria : June 24, 2016
Certification/Extension First Posted : June 29, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : May 11, 2017
Last Update Posted : June 12, 2017